Drug Shortage Report for TWYNSTA
Report ID | 123133 |
Drug Identification Number | 02371057 |
Brand name | TWYNSTA |
Common or Proper name | Twynsta |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN AMLODIPINE |
Strength(s) | 80MG 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 28's |
ATC code | C09DB |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-08-31 |
Actual start date | 2020-09-11 |
Estimated end date | 2020-09-28 |
Actual end date | 2020-09-18 |
Shortage status | Resolved |
Updated date | 2020-09-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-09-19 | English | Compare |
v5 | 2020-09-18 | French | Compare |
v4 | 2020-09-18 | English | Compare |
v3 | 2020-09-01 | English | Compare |
v2 | 2020-08-28 | French | Compare |
v1 | 2020-08-28 | English | Compare |
Showing 1 to 6 of 6